Shan Liu

Shan Liu, J.D., Ph.D., is a Senior Counsel at GSK (GlaxoSmithKline) specializing in patent law and intellectual property in the pharmaceutical industry.1 Here are some key details about her background and experience:

Professional Experience

Current Role:: Senior Counsel (Patents) at GSK since July 20221

Previous Roles::

• Patent Counsel at GSK (February 2021 - July 2022)
• Associate/Patent Attorney at Wilson Sonsini Goodrich & Rosati (August 2018 - February 2021)
• Patent Agent at Wilson Sonsini Goodrich & Rosati (September 2012 - August 2018)
• Technology Transfer Fellow/Patent Agent at National Institute of Allergy and Infectious Diseases (NIAID) (February 2011 - July 2011)

Education and Qualifications

• J.D. from The George Washington University Law School (2015 - 2018)
• Ph.D. in Chemistry from The University of Georgia (2003 - 2008)
• B.S. in Chemistry from Beijing University of Chemical Technology (1999 - 2003)
• Regulatory Affairs Certification (RAC) - Drugs from the Regulatory Affairs Professionals Society

Areas of Expertise

Shan Liu focuses on:

• IP support for clinical programs, including oncology
• Regulatory compliance
• Product commercialization
• Transaction due diligence
• Contract review and negotiation
• Patent strategies and loss of exclusivity
• Global patent portfolio management
• Collaboration and license agreements

Additional Information

• Trained in technology transfer at the National Institutes of Health (NIH)
• Postdoctoral research experience in proteins and structural biology
• Member of the 2022 class of Leadership Council on Legal Diversity (LCLD) Pathfinders
• Admitted to practice before the Bar of the District of Columbia and the U.S. Patent and Trademark Office

Shan Liu's diverse background in chemistry, law, and regulatory affairs, combined with her extensive experience in patent law and the pharmaceutical industry, makes her a valuable asset in her role as Senior Counsel at GSK.1